Axsome Beats Securities Suit Over Migraine Drug, For Now
By Henrik Nilsson · September 26, 2023, 7:53 PM EDT
A New York federal judge on Monday tossed a proposed securities class action alleging that biopharmaceutical company Axsome hid issues about its migraine drug, leading to a significant stock price drop,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login